AstraZeneca Current Affairs, GK & News

SII’s Covishield gets emergency-use nod from DGCI

January 2, 2021

The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..

Month: 

Category: 

Topics:  • • • • • • • •

What is mRNA Technology used in COVID-19 vaccines for the first time?

November 17, 2020

On November 16, 2020, Moderna, a US Biotech firm announced that its COVID-19 vaccines are 94.5% effective. The announcement comes in days after Pfizer released results showing 90% effectiveness in its own vaccine. Both the companies use mRNA technology in their vaccines. This is the first time the mRNA technology is being used to create ..

Month: 

Category: 

Topics:  • • • • • • • • •

EU enters into deal with AstraZeneca, for first Covid-19 vaccine

August 15, 2020

The European Union has entered into an agreement to but at least 300 million doses of AstraZeneca’s potential COVID 19 vaccine in the first-ever such deal in advance by the group. This is expected to weaken the global approach taken by the World Health Organization in this regard. What is the Deal? The European Union, ..

Month: 

Category:  •

Topics:  • • • • •

National Expert Group on Vaccine Administration for COVID-19 chaired by Dr V K Paul met for the first time

August 13, 2020

The National Expert Group on Vaccine Administration for COVID 19 met for the first time on August 13 to discuss regarding the delivery of vaccines in the country. They mainly discussed the conceptualization and implementation mechanisms for the creation of a digital infrastructure for inventory management and delivery mechanism for the vaccine. Details of the ..

Month: 

Category: 

Topics:  • • • • • • • •